According to Silence Therapeutics's latest financial reports the company has โน14.96 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | โน5.73 B | -19.54% |
2022-12-31 | โน7.12 B | -3.6% |
2021-12-31 | โน7.38 B | 97.91% |
2020-12-31 | โน3.73 B | 19.11% |
2019-12-31 | โน3.13 B | 33.06% |
2018-12-31 | โน2.35 B | -36.62% |
2017-12-31 | โน3.71 B | 13.61% |
2016-12-31 | โน3.27 B | -36.01% |
2015-12-31 | โน5.11 B | 137.02% |
2014-12-31 | โน2.15 B | 1.31% |
2013-12-31 | โน2.12 B | 170.01% |
2012-12-31 | โน0.78 B | 160% |
2011-12-31 | โน0.30 B | 22.93% |
2010-12-31 | โน0.24 B | 190.48% |
2009-12-31 | โน84.92 M | -64.02% |
2008-12-31 | โน0.23 B | -70.25% |
2007-12-31 | โน0.79 B | 3.62% |
2006-12-31 | โน0.76 B | 8.51% |
2005-12-31 | โน0.70 B | 222.38% |
2004-12-31 | โน0.21 B | -47.24% |
2003-12-31 | โน0.41 B | -24.64% |
2002-12-31 | โน0.55 B | -13.31% |
2001-12-31 | โน0.63 B | -20.22% |
2000-12-31 | โน0.79 B | 7.62% |
1999-12-31 | โน0.73 B | 185.68% |
1998-12-31 | โน0.25 B | -22.64% |
1997-12-31 | โน0.33 B | -18.92% |
1996-12-31 | โน0.41 B |